Results 181 to 190 of about 176,256 (304)

Confined B‐Cell Reconstruction and High T‐Cell Clonality Define Clinical Response to Cladribine Treatment

Annals of Neurology, Volume 99, Issue 5, Page 1166-1172, May 2026.
Cladribine tablets are approved for relapsing multiple sclerosis, mediating their clinical effect by moderately depleting lymphocytes. In a prospective, monocentric study including 22 patients completing 2 annual cycles of cladribine, B‐ and T‐cell receptor repertoires and relapse activity were assessed at baseline and after 24 months. T‐cell clonality
Tilman Schneider‐Hohendorf, Maria Eveslage, Timo Wirth, Christian Wünsch, Eva M. Schumann, Jan D. Lünemann, Heinz Wiendl, Luisa Klotz, Nicholas Schwab   +8 more
wiley   +1 more source

Thyroid Hormone in Women with Premature Ovarian Insufficiency: A Case-Control Study. [PDF]

Int J Womens Health
Zhang Y, Huang Y, Xu Y, Luo Z, Xu L, Ma L, Zhou J.   +6 more
europepmc   +1 more source

Physiology of the hypothalamo-pituitary unit [PDF]

, 1978
Fahlbusch, R., Pickardt, C. R., Scriba, Peter Christian, Werder, Klaus von, Werder, Klaus von   +4 more
core   +1 more source

Immunotherapy and Breast Reconstruction: Opportunities, Challenges, and Future Directions

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Immunotherapy is transforming breast cancer management, but it also presents new challenges for surgical and reconstructive practice. This review summarizes current evidence on immune checkpoint inhibitors, perioperative safety, and immune‐related adverse events, highlighting their impact on surgical timing, postoperative recovery, and ...
Shuang Li, Jianguo Wang, Yingjie Liu, Wenwu Cai, Weichang Zhang, Shengyun Li, Yunjian Zhang   +6 more
wiley   +1 more source

Fruquintinib Plus TAS‐102 With or Without SBRT as Third‐ Or Later‐Line Therapy for Metastatic Colorectal Cancer: Preliminary Results From a Prospective Phase II Trial

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Both fruquintinib and TAS‐102 monotherapies are guideline‐recommended for third‐line treatment of metastatic colorectal cancer (mCRC). This study aimed to analyze the preliminary outcomes of fruquintinib combined with TAS‐102, with or without stereotactic body radiation therapy (SBRT), as a third‐ or later‐line therapy for mCRC.
Yi Wang, Jianfen Xu, Linchun Liang, Yunjie Chen, Leizheng Fei, Jing Hu, Jianjiong Li, Yi Lu, Feng Ren, Ke Chen, Yanping Shen, Qingsong Tao, Zhi Fang, Kaitai Liu, Hua Ye, Jing Zhang, Yunbao Xu, Haoxun Mao, Chen Zhang, Chuangzhou Rao   +19 more
wiley   +1 more source

Severe hyperprolactinemia secondary to primary hypothyroidism with normal pituitary imaging. [PDF]

JCEM Case Rep
Meena A.
europepmc   +1 more source

Development of a Machine Learning‐Based Predictive Model for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Central lymph nodes metastasis (CLNM) is common in papillary thyroid. Microcarcinoma (PTMC). Whilst prophylactic central lymph node dissection (CLND) can prevent further CLNM, it remains controversial. An accurate model to predict CLNM is therefore necessary for patients with PTMC.
Tao Li, Thomas O. Butler, Yaopeng Hu, Sha Li   +3 more
wiley   +1 more source

TSH suppression attenuates the early efficacy of zoledronic acid in osteoporosis. [PDF]

Arch Osteoporos
Liu Y, Zhang Y, Li M, Qian Y, Zhang Z, Jiang Z, Qu W.   +6 more
europepmc   +1 more source

Not Only Enteropathy: The Overlooked “Gastric Side” of Olmesartan

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Several medications can be associated with gastrointestinal adverse effects. Olmesartan has been linked to a broad spectrum of gastrointestinal injuries. Although sprue‐like enteropathy is well known, less common involvements such as gastropathy can be equally debilitating.
Cecilia Lina Pugliano, Stefania Piccirelli, Denise Bianchi, Clarissa Ferrari, Cristiano Spada, Paola Cesaro   +5 more
wiley   +1 more source

Cardiac Tamponade, Pituitary Hyperplasia, and Macroorchidism in Severe Primary Hypothyroidism. [PDF]

JCEM Case Rep
Saha S, Basu R, Singha H, Chakrabarti SK.   +3 more
europepmc   +1 more source